Publications

Anti-Tac monoclonal antibody identifies the receptor for interleukin 2 (IL 2, or T cell growth factor) present on activated human T lymphocytes. By using tritiated anti-Tac, we now report a sensitive and specific binding assay to evaluate cell surface IL 2 receptor expression. IL 2 receptors on human peripheral blood lymphocytes can be detected within 6 hr after PHA stimulation. PHA-induced receptor expression is inhibited by actinomycin D and cycloheximide, but not by mitomycin C, suggesting a requirement for de novo RNA and protein synthesis, but not DNA synthesis. Scatchard analysis of [3H]-anti-Tac binding to lymphocytes stimulated with PHA for 3 days revealed from 20,000 to 60,000 molecules of antibody bound per cell, and a Kd of 1 to 3 x 10(-10) mol/l. Sequential binding studies of activated human lymphocytes maintained in long-term culture with IL 2 demonstrated a progressive decline in receptor number correlating with diminished growth rate. Restimulation with lectin or antigen increased the number of IL 2 receptors, suggesting that IL 2 dependent immune responses may be regulated, at least in part, by IL 2 receptor expression. Receptor number was also increased by PMA. Moreover, similar effects were produced by incubation with phospholipase C but not interleukin 1. Because both PMA and phospholipase C result in activation of protein kinase C, these data suggest the possibility that activation of protein kinase C may induce IL 2 receptor expression.

The normal decline in systolic blood pressure (SBP) during the recovery phase of treadmill exercise does not occur in some patients with coronary artery disease (CAD). In others the recovery values of SBP exceed the peak exercise values. To examine the diagnostic value of this observation, we studied 31 normal subjects and 56 patients undergoing treadmill exercise before coronary cineangiography. Because of large differences in peak exercise pressures between the two groups, recovery ratios were derived by dividing the SBP at 1, 2, and 3 min after exercise by the peak exercise SBP. The 1, 2, and 3 min ratios in the normal subjects declined steadily from 0.85 +/- 0.07 (SD) to 0.79 +/- 0.06 and to 0.73 +/- 0.06, respectively, while the ratios in the patients with CAD remained elevated at 0.97 +/- 0.12 to 0.97 +/- 0.11 to 0.93 +/- 0.13. With use of the upper limits defined by two SDs of the normal value, recovery ratios were compared with the occurrence of angina and with ST segment depression on the exercise electrocardiogram in the patients with CAD. Abnormal ratios were more frequent in patients with CAD (53/56, 95%) than in those with ST segment depression (33/56, 59%), angina (37/56, 66%), and either ST segment depression or angina (42/56, 75%). Twenty of the patients with CAD who were on no medication underwent an additional treadmill exercise test on a separate day and no significant differences were found in the ratios from the two tests. Ten additional patients with CAD underwent treadmill exercise testing while on placebo and while on a beta-blocker.(ABSTRACT TRUNCATED AT 250 WORDS)